Table 4

Comparison of outcomes from current ADAPT FAST, SWIFT, TREVO, NASA, and stent retriever meta-analysis

SWIFT trial
TREVO trial
STAR study
NASA registry
Solitaire data*
Trevo data*
TICI 2a/2b/3 (%)N/A83†90N/A87.58283
Device TICI 2b/3 (%)7875.9‡68‡79‡
Final TICI 2b/3 (%)9575.9‡68‡8572.58283
mRS 0–2 (%)40364055424751
Mortality (%)2017341930.21431
Time to final revascularization (min)37NRNRNR50¶NRNR
Device related complications (%)28.697.5NR65
Symptomatic ICH (%)02749.968
  • *Meta-analysis of real world published experience.

  • †Site reported rate of recanalization.

  • ‡Core laboratory reported.

  • §Site investigator reported data.

  • ¶Time to revascularize after guide catheter access.

  • ICH, intracerebral hemorrhage; mRS, modified Rankin Scale; N/A, not applicable; NR, not reported; TICI, Thrombolysis in Cerebral Infarction.